Tue, February 28, 2023

Michael Schmidt Reiterated (BGNE) at Strong Buy and Held Target at $350 on, Feb 28th, 2023

Michael Schmidt of Guggenheim, Reiterated "BeiGene, Ltd." (BGNE) at Strong Buy and Held Target at $350 on, Feb 28th, 2023.

Michael has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $300 on, Friday, January 20th, 2023